Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Intramuscular Oxytocin on Pupil Diameter and Heart Rate Variability
NCT04105998Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2019
- Primary completion
- Nov 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in chronic pain, sponsored by Wake Forest University Health Sciences. Primary endpoints: Fluctuation in Pupil Diameter at 120 months and Heart Rate Variability in the High Frequency Range at 120 months. Started Oct 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04105998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04105998.